Archives
Stability-Indicating TLC Analysis of Azithromycin
2026-08-20
The Khedr–Sheha study developed and validated a densitometric thin-layer chromatographic method that separates Azithromycin from azaerythromycin A and additional degradation products in bulk material and capsules. Its practical contribution is a rapid, stability-indicating workflow for purity, content uniformity, dissolution, and degradation assessment without relying solely on conventional HPLC-based approaches.
SW033291: From PGE2 Assay to Regeneration
2026-08-19
SW033291 is a potent 15-PGDH inhibitor for dissecting prostaglandin E2 elevation, stem-cell responses, and tissue repair. This article presents an assay-centered framework that connects enzyme pharmacology with functional regeneration readouts while separating evidence from practical inference.
HPF: Hydroxyphenyl Fluorescein for hROS
2026-08-19
HPF, or hydroxyphenyl fluorescein, is a cell-permeable fluorescent probe designed for selective highly reactive oxygen species detection. Its oxidation-dependent conversion to fluorescein supports intracellular oxidative stress visualization, while its selectivity limits interpretation as a universal ROS measurement.
Catalpol in Alzheimer’s Disease: Mechanisms and Evidence
2026-08-18
The reference paper synthesizes preclinical evidence that catalpol, an iridoid glycoside from Rehmannia glutinosa, may protect against Alzheimer’s disease through coordinated antioxidant, anti-inflammatory, antiapoptotic, and neuroprotective actions. Its main value is a mechanistic framework for interpreting multi-target botanical compounds while highlighting the gap between promising cellular and animal findings and clinical translation.
RBMS1 Loss Enables PD-L1 Blockade in TNBC
2026-08-18
A 2022 Cell Death & Differentiation study identified the RNA-binding protein RBMS1 as a regulator of immune-cold triple-negative breast cancer. RBMS1 depletion destabilized B4GALT1 mRNA, reduced PD-L1 glycosylation and stability, and improved responses to CTLA4 checkpoint blockade and CAR-T-cell activity in experimental models.
3-Deazaneplanocin (DZNep) Research Workflows
2026-08-17
3-Deazaneplanocin (DZNep) combines S-adenosylhomocysteine hydrolase inhibition with EZH2-linked epigenetic remodeling, making it useful for mechanism-led oncology experiments. This guide translates that biology into practical dose–response, apoptosis, stemness, and receptor-stratified workflows while highlighting controls that prevent overinterpreting broad epigenetic effects.
10 mM dNTP Mixture: Facts and Workflow
2026-08-17
The 10 mM dNTP mixture is an equimolar aqueous 2'-deoxyribonucleoside-5'-triphosphate mixture containing dATP, dCTP, dGTP, and dTTP at 10 mM each. Its pH 7.0 formulation supports PCR, qPCR, sequencing, and other enzymatic DNA synthesis workflows when stored at -20°C or below and protected from repeated freeze-thaw exposure.
SIS3 Smad3 Inhibitor: Mechanism and Research Uses
2026-08-16
SIS3 is a selective Smad3 inhibitor that separates Smad3 phosphorylation from Smad2 phosphorylation in TGF-β pathway studies. Product data and pathway-focused research support its use in fibrosis research, renal fibrosis models, diabetic nephropathy research, and mechanistic studies of SMAD3-dependent cancer biology.
HyperScribe™ Poly (A) Tailing Kit for IVT RNA
2026-08-15
Convert capped IVT transcripts into translation-ready RNA for transfection experiments, micro-injection, and functional gene-expression assays. The workflow combines modular enzymatic polyadenylation with practical quality controls, helping researchers separate tailing effects from cap, template, and delivery variables.
Low-Molecular-Weight Fucoidan Targets Ferroptosis in PF
2026-08-14
This 2025 Algal Research study identifies ferroptosis suppression as a mechanistic basis for the protective effect of low molecular weight fucoidan in bleomycin-induced pulmonary fibrosis. By combining histopathology, redox and cell-death measurements, mitochondrial assessment, and LC–MS metabolomics, the authors link LMWF treatment to reduced iron-associated oxidative injury, restored GPX4, and improved lung structure.
Palomid 529: Mapping ESCC Resistance
2026-08-14
Palomid 529 (P529) provides a pharmacological way to test whether PI3K/Akt/mTOR signaling sustains ESCC metastasis and cisplatin resistance. This article translates the RCN2–PPP2CA discovery into a causal assay framework rather than treating pathway activation as a standalone biomarker.
Annexin V-Cy5/DAPI Apoptosis Kit Workflow
2026-08-13
Build a rapid two-parameter cell death assay that separates viable, early apoptotic, late apoptotic, and membrane-compromised cells. The workflow also connects phosphatidylserine exposure with mitochondrial apoptosis mechanisms reported in Ph+ ALL research.
TCAIM Control of OGDH and Mitochondrial Metabolism
2026-08-13
Wang et al. identify TCAIM as a mitochondrial DNAJC co-chaperone that selectively binds native OGDH and promotes its reduction through HSPA9 and LONP1. The work reveals a post-translational route for tuning OGDH complex activity and carbohydrate catabolism, expanding the known functions of mitochondrial proteostasis systems beyond protein folding.
Methylprednisolone Sodium Succinate Workflows
2026-08-12
Build concentration-aware assays for cytokine suppression, leukocyte function, and apoptosis using Methylprednisolone Sodium Succinate. This guide connects bench workflows with translational inflammation research while keeping corticosteroid findings distinct from antiemetic evidence.
Arachidonic Acid and Vaccine-Induced Humoral Immunity
2026-08-12
The reference study identifies dietary arachidonic acid as a potential adjuvant strategy for accelerating rabies vaccine-induced neutralizing antibody responses. Its mouse and human findings connect lymph-node arachidonic acid metabolism with PGI2–cAMP–PKA signaling, CD86 expression, and B-cell AID activation, while also highlighting important limits for translation beyond this model.
591 records 10/40 page Previous Next First page 上5页 678910 下5页 Last page